Heparin-induced thrombocytopenia: an overview

Babcock, 1976, Heparin-induced immune thrombocytopenia, N Engl J Med, 295, 237, 10.1056/NEJM197607292950501

Kelton, 1988, Heparin-induced thrombocytopenia: laboratory studies, Blood, 72, 925, 10.1182/blood.V72.3.925.bloodjournal723925

Warkentin, 2000, Impact of the patient population on the risk for heparin-induced thrombocytopenia, Blood, 96, 1703, 10.1182/blood.V96.5.1703

Horsewood, 2000, Investigation of a platelet factor 4 polymorphism on the immune response in patients with heparin-induced thrombocytopenia, Platelets, 11, 23, 10.1080/09537100075751

Tardy-Poncet, 2000, Heparin-induced thrombocytopenia: minimizing the risks in the elderly patient, Drugs Aging, 16, 351, 10.2165/00002512-200016050-00005

Amiral, 1992, Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia [letter], Thromb Haemost, 68, 95, 10.1055/s-0038-1656329

Greinacher, 1994, Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen, Thromb Haemost, 71, 247

Kelton, 1994, Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4, Blood, 83, 3232, 10.1182/blood.V83.11.3232.3232

Visentin, 1994, Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells, J Clin Invest, 93, 81, 10.1172/JCI116987

Hughes, 2000, Morphological analysis of microparticle generation in heparin-induced thrombocytopenia, Blood, 96, 188, 10.1182/blood.V96.1.188

Newman, 2000, Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation, Blood, 96, 182, 10.1182/blood.V96.1.182

Walenga, 2000, Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia, J Thromb Thrombolysis, 10, 13, 10.1023/A:1027372901367

Ahmad, 1999, Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome, Clin Appl Thromb Hemost, 5, S32, 10.1177/107602969900500107

Greinacher, 1994, Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay, Transfusion, 34, 381, 10.1046/j.1537-2995.1994.34594249047.x

Walenga, 1999, Laboratory diagnosis of heparin-induced thrombocytopenia, Clin Appl Thromb Hemost, 5, S21, 10.1177/107602969900500105

Elalamy, 2000, Heparin-induced thrombocytopenia: laboratory diagnosis and management, Ann Med, 32, 60

Warkentin, 1997, The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia, Ann Intern Med, 127, 804, 10.7326/0003-4819-127-9-199711010-00005

Warkentin, 2000, Venous thromboembolism in heparin-induced thrombocytopenia, Curr Opin Pulm Med, 6, 343, 10.1097/00063198-200007000-00016

Warkentin, 1996, A 14-year study of heparin-induced thrombocytopenia, Am J Med, 101, 502, 10.1016/S0002-9343(96)00258-6

Wilde, 1997, Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia, Drugs, 54, 903, 10.2165/00003495-199754060-00008

Baumgartel, 2000, Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin), Eur J Haematol, 65, 148, 10.1034/j.1600-0609.2000.9l225.x

Greinacher, 2000, Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range, Blood, 96, 846, 10.1182/blood.V96.3.846

Hursting, 1997, Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor, Semin Thromb Hemost, 23, 503, 10.1055/s-2007-996128

Lewis, 1996, Successful coronary interventions performed with argatroban anticoagulation in patients with heparin-induced thrombocytopenia and thrombosis syndrome, J Invasive Cardiol, 8, 410

Lewis, 1997, Anticoagulation with Novastan (argatroban) in patients with heparin-nduced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome, Semin Thromb Hemost, 23, 197, 10.1055/s-2007-996091

Walenga, 1999, Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in-patients with HIT, Semin Thromb Hemost, 25, 77